Global Bipolar Disorder Therapeutics Drugs Sales Market Report 2021

The global Bipolar Disorder Therapeutics Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Olanzapine (Zyprexa)

Quetiapine (Seroquel)

Risperidone (Risperdal)

Ariprazole (Abilify)

Ziprasidone (Geodon)

Clozapine (Clozaril)

lumateperone

Central Nervous System (CNS) Disorders

The Bipolar Disorder Therapeutics Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Bipolar Disorder Therapeutics Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

AstraZeneca

Allergan

Bristol-Myers Squibb

GSK

Janssen

AbbVie

Youdim

Delpor

Lundbeck

Intra-Cellular Therapies

Novartis Pharmaceuticals Corporation

Noven Pharmaceuticals

Otsuka

Pfizer

Reviva Pharmaceuticals

1.1 Bipolar Disorder Therapeutics Drugs Product Scope

1.2 Bipolar Disorder Therapeutics Drugs Segment by Type

1.2.1 Global Bipolar Disorder Therapeutics Drugs Sales by Type (2016 & 2021 & 2027)

1.2.2 Olanzapine (Zyprexa)

1.2.3 Quetiapine (Seroquel)

1.2.4 Risperidone (Risperdal)

1.2.5 Ariprazole (Abilify)

1.2.6 Ziprasidone (Geodon)

1.2.7 Clozapine (Clozaril)

1.3 Bipolar Disorder Therapeutics Drugs Segment by Application

1.3.1 Global Bipolar Disorder Therapeutics Drugs Sales Comparison by Application (2016 & 2021 & 2027)

1.3.2 lumateperone

1.3.3 Central Nervous System (CNS) Disorders

1.4 Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts (2016-2027)

1.4.1 Global Bipolar Disorder Therapeutics Drugs Market Size in Value Growth Rate (2016-2027)

1.4.2 Global Bipolar Disorder Therapeutics Drugs Market Size in Volume Growth Rate (2016-2027)

1.4.3 Global Bipolar Disorder Therapeutics Drugs Price Trends (2016-2027)

2.1 Global Bipolar Disorder Therapeutics Drugs Market Size by Region: 2016 VS 2021 VS 2027

2.2 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario by Region (2016-2021)

2.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2021)

2.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2016-2021)

2.3 Global Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Region (2022-2027)

2.3.1 Global Bipolar Disorder Therapeutics Drugs Sales Estimates and Forecasts by Region (2022-2027)

2.3.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Region (2022-2027)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 North America Bipolar Disorder Therapeutics Drugs Estimates and Projections (2016-2027)

2.4.2 Europe Bipolar Disorder Therapeutics Drugs Estimates and Projections (2016-2027)

2.4.3 China Bipolar Disorder Therapeutics Drugs Estimates and Projections (2016-2027)

2.4.4 Japan Bipolar Disorder Therapeutics Drugs Estimates and Projections (2016-2027)

2.4.5 Southeast Asia Bipolar Disorder Therapeutics Drugs Estimates and Projections (2016-2027)

2.4.6 India Bipolar Disorder Therapeutics Drugs Estimates and Projections (2016-2027)

3.1 Global Top Bipolar Disorder Therapeutics Drugs Players by Sales (2016-2021)

3.2 Global Top Bipolar Disorder Therapeutics Drugs Players by Revenue (2016-2021)

3.3 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2020)

3.4 Global Bipolar Disorder Therapeutics Drugs Average Price by Company (2016-2021)

3.5 Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Global Bipolar Disorder Therapeutics Drugs Historic Market Review by Type (2016-2021)

4.1.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)

4.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2016-2021)

4.1.3 Global Bipolar Disorder Therapeutics Drugs Price by Type (2016-2021)

4.2 Global Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Type (2022-2027)

4.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2022-2027)

4.2.3 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2022-2027)

5.1 Global Bipolar Disorder Therapeutics Drugs Historic Market Review by Application (2016-2021)

5.1.1 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)

5.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2016-2021)

5.1.3 Global Bipolar Disorder Therapeutics Drugs Price by Application (2016-2021)

5.2 Global Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Application (2022-2027)

5.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Application (2022-2027)

5.2.3 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2022-2027)

6.1 North America Bipolar Disorder Therapeutics Drugs Sales by Company

6.1.1 North America Bipolar Disorder Therapeutics Drugs Sales by Company (2016-2021)

6.1.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021)

6.2 North America Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type

6.2.1 North America Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2016-2021)

6.2.2 North America Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2022-2027)

6.3 North America Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application

6.3.1 North America Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application (2016-2021)

6.3.2 North America Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application (2022-2027)

7.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Company

7.1.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Company (2016-2021)

7.1.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021)

7.2 Europe Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type

7.2.1 Europe Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2016-2021)

7.2.2 Europe Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2022-2027)

7.3 Europe Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application

7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)

7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8.1 China Bipolar Disorder Therapeutics Drugs Sales by Company

8.1.1 China Bipolar Disorder Therapeutics Drugs Sales by Company (2016-2021)

8.1.2 China Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021)

8.2 China Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type

8.2.1 China Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2016-2021)

8.2.2 China Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2022-2027)

8.3 China Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application

8.3.1 China 317 Sales Breakdown by Application (2016-2021)

8.3.2 China 317 Sales Breakdown by Application (2022-2027)

9.1 Japan Bipolar Disorder Therapeutics Drugs Sales by Company

9.1.1 Japan Bipolar Disorder Therapeutics Drugs Sales by Company (2016-2021)

9.1.2 Japan Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021)

9.2 Japan Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type

9.2.1 Japan Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2016-2021)

9.2.2 Japan Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2022-2027)

9.3 Japan Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application

9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)

9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10.1 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales by Company

10.1.1 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales by Company (2016-2021)

10.1.2 Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021)

10.2 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type

10.2.1 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2016-2021)

10.2.2 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2022-2027)

10.3 Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application

10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)

10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11.1 India Bipolar Disorder Therapeutics Drugs Sales by Company

11.1.1 India Bipolar Disorder Therapeutics Drugs Sales by Company (2016-2021)

11.1.2 India Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021)

11.2 India Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type

11.2.1 India Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2016-2021)

11.2.2 India Bipolar Disorder Therapeutics Drugs Sales Breakdown by Type (2022-2027)

11.3 India Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application

11.3.1 India Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application (2016-2021)

11.3.2 India Bipolar Disorder Therapeutics Drugs Sales Breakdown by Application (2022-2027)

12.1 AstraZeneca

12.1.1 AstraZeneca Corporation Information

12.1.2 AstraZeneca Business Overview

12.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Products Offered

12.1.5 AstraZeneca Recent Development

12.2 Allergan

12.2.1 Allergan Corporation Information

12.2.2 Allergan Business Overview

12.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.2.4 Allergan Bipolar Disorder Therapeutics Drugs Products Offered

12.2.5 Allergan Recent Development

12.3 Bristol-Myers Squibb

12.3.1 Bristol-Myers Squibb Corporation Information

12.3.2 Bristol-Myers Squibb Business Overview

12.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Products Offered

12.3.5 Bristol-Myers Squibb Recent Development

12.4 GSK

12.4.1 GSK Corporation Information

12.4.2 GSK Business Overview

12.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.4.4 GSK Bipolar Disorder Therapeutics Drugs Products Offered

12.4.5 GSK Recent Development

12.5 Janssen

12.5.1 Janssen Corporation Information

12.5.2 Janssen Business Overview

12.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.5.4 Janssen Bipolar Disorder Therapeutics Drugs Products Offered

12.5.5 Janssen Recent Development

12.6 AbbVie

12.6.1 AbbVie Corporation Information

12.6.2 AbbVie Business Overview

12.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Products Offered

12.6.5 AbbVie Recent Development

12.7 Youdim

12.7.1 Youdim Corporation Information

12.7.2 Youdim Business Overview

12.7.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.7.4 Youdim Bipolar Disorder Therapeutics Drugs Products Offered

12.7.5 Youdim Recent Development

12.8 Delpor

12.8.1 Delpor Corporation Information

12.8.2 Delpor Business Overview

12.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.8.4 Delpor Bipolar Disorder Therapeutics Drugs Products Offered

12.8.5 Delpor Recent Development

12.9 Lundbeck

12.9.1 Lundbeck Corporation Information

12.9.2 Lundbeck Business Overview

12.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Products Offered

12.9.5 Lundbeck Recent Development

12.10 Intra-Cellular Therapies

12.10.1 Intra-Cellular Therapies Corporation Information

12.10.2 Intra-Cellular Therapies Business Overview

12.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Products Offered

12.10.5 Intra-Cellular Therapies Recent Development

12.11 Novartis Pharmaceuticals Corporation

12.11.1 Novartis Pharmaceuticals Corporation Corporation Information

12.11.2 Novartis Pharmaceuticals Corporation Business Overview

12.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.11.4 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Products Offered

12.11.5 Novartis Pharmaceuticals Corporation Recent Development

12.12 Noven Pharmaceuticals

12.12.1 Noven Pharmaceuticals Corporation Information

12.12.2 Noven Pharmaceuticals Business Overview

12.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.12.4 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Products Offered

12.12.5 Noven Pharmaceuticals Recent Development

12.13 Otsuka

12.13.1 Otsuka Corporation Information

12.13.2 Otsuka Business Overview

12.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.13.4 Otsuka Bipolar Disorder Therapeutics Drugs Products Offered

12.13.5 Otsuka Recent Development

12.14 Pfizer

12.14.1 Pfizer Corporation Information

12.14.2 Pfizer Business Overview

12.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.14.4 Pfizer Bipolar Disorder Therapeutics Drugs Products Offered

12.14.5 Pfizer Recent Development

12.15 Reviva Pharmaceuticals

12.15.1 Reviva Pharmaceuticals Corporation Information

12.15.2 Reviva Pharmaceuticals Business Overview

12.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)

12.15.4 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Products Offered

12.15.5 Reviva Pharmaceuticals Recent Development

13.1 Bipolar Disorder Therapeutics Drugs Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs

13.4 Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis

14.1 Marketing Channel

14.2 Bipolar Disorder Therapeutics Drugs Distributors List

14.3 Bipolar Disorder Therapeutics Drugs Customers

15.1 Bipolar Disorder Therapeutics Drugs Market Trends

15.2 Bipolar Disorder Therapeutics Drugs Drivers

15.3 Bipolar Disorder Therapeutics Drugs Market Challenges

15.4 Bipolar Disorder Therapeutics Drugs Market Restraints

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

    Table 1. Global Bipolar Disorder Therapeutics Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)

    Table 2. Global Bipolar Disorder Therapeutics Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)

    Table 3. Global Bipolar Disorder Therapeutics Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027

    Table 4. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Region (2016-2021)

    Table 5. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2021)

    Table 6. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Region (2016-2021))

    Table 7. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Region (2016-2021)

    Table 8. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Forecast by Region (2022-2027)

    Table 9. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027)

    Table 10. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Forecast by Region (2022-2027)

    Table 11. Global Bipolar Disorder Therapeutics Drugs Revenue Share Forecast by Region (2022-2027)

    Table 12. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) of Key Companies (2016-2021)

    Table 13. Global Bipolar Disorder Therapeutics Drugs Sales Share by Company (2016-2021)

    Table 14. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) by Company (2016-2021)

    Table 15. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Company (2016-2021)

    Table 16. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2020)

    Table 17. Global Bipolar Disorder Therapeutics Drugs Average Price (USD/Unit) of Key Company (2016-2021)

    Table 18. Manufacturers Bipolar Disorder Therapeutics Drugs Manufacturing Sites and Area Served

    Table 19. Manufacturers Bipolar Disorder Therapeutics Drugs Product Type

    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 21. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2016-2021)

    Table 22. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2016-2021)

    Table 23. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2016-2021)

    Table 24. Global Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Type (2016-2021)

    Table 25. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2022-2027)

    Table 26. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2022-2027)

    Table 27. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2022-2027)

    Table 28. Global Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Type (2022-2027)

    Table 29. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2016-2021)

    Table 30. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2016-2021)

    Table 31. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2016-2021)

    Table 32. Global Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Application (2016-2021)

    Table 33. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2022-2027)

    Table 34. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2022-2027)

    Table 35. Global Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2022-2027)

    Table 36. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2022-2027)

    Table 37. Global Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Application (2022-2027)

    Table 38. North America Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2016-2021)

    Table 39. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2016-2021)

    Table 40. North America Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)

    Table 41. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Company (2016-2021)

    Table 42. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021) & (K Units)

    Table 43. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)

    Table 44. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2022-2027) & (K Units)

    Table 45. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2022-2027)

    Table 46. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021) & (K Units)

    Table 47. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)

    Table 48. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2022-2027) & (K Units)

    Table 49. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2022-2027)

    Table 50. Europe Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2016-2021)

    Table 51. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2016-2021)

    Table 52. Europe Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)

    Table 53. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Company (2016-2021)

    Table 54. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021) & (K Units)

    Table 55. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)

    Table 56. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2022-2027) & (K Units)

    Table 57. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2022-2027)

    Table 58. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021) & (K Units)

    Table 59. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)

    Table 60. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2022-2027) & (K Units)

    Table 61. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2022-2027)

    Table 62. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2016-2021)

    Table 63. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2016-2021)

    Table 64. China Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)

    Table 65. China Bipolar Disorder Therapeutics Drugs Revenue Market Share by Company (2016-2021)

    Table 66. China Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021) & (K Units)

    Table 67. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)

    Table 68. China Bipolar Disorder Therapeutics Drugs Sales by Type (2022-2027) & (K Units)

    Table 69. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2022-2027)

    Table 70. China Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021) & (K Units)

    Table 71. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)

    Table 72. China Bipolar Disorder Therapeutics Drugs Sales by Application (2022-2027) & (K Units)

    Table 73. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2022-2027)

    Table 74. Japan Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2016-2021)

    Table 75. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2016-2021)

    Table 76. Japan Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)

    Table 77. Japan Bipolar Disorder Therapeutics Drugs Revenue Market Share by Company (2016-2021)

    Table 78. Japan Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021) & (K Units)

    Table 79. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)

    Table 80. Japan Bipolar Disorder Therapeutics Drugs Sales by Type (2022-2027) & (K Units)

    Table 81. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2022-2027)

    Table 82. Japan Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021) & (K Units)

    Table 83. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)

    Table 84. Japan Bipolar Disorder Therapeutics Drugs Sales by Application (2022-2027) & (K Units)

    Table 85. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2022-2027)

    Table 86. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2016-2021)

    Table 87. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2016-2021)

    Table 88. Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)

    Table 89. Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue Market Share by Company (2016-2021)

    Table 90. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021) & (K Units)

    Table 91. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)

    Table 92. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales by Type (2022-2027) & (K Units)

    Table 93. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2022-2027)

    Table 94. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021) & (K Units)

    Table 95. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)

    Table 96. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales by Application (2022-2027) & (K Units)

    Table 97. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2022-2027)

    Table 98. India Bipolar Disorder Therapeutics Drugs Sales (K Units) by Company (2016-2021)

    Table 99. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Company (2016-2021)

    Table 100. India Bipolar Disorder Therapeutics Drugs Revenue by Company (2016-2021) & (US$ Million)

    Table 101. India Bipolar Disorder Therapeutics Drugs Revenue Market Share by Company (2016-2021)

    Table 102. India Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021) & (K Units)

    Table 103. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)

    Table 104. India Bipolar Disorder Therapeutics Drugs Sales by Type (2022-2027) & (K Units)

    Table 105. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2022-2027)

    Table 106. India Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021) & (K Units)

    Table 107. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)

    Table 108. India Bipolar Disorder Therapeutics Drugs Sales by Application (2022-2027) & (K Units)

    Table 109. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2022-2027)

    Table 110. AstraZeneca Corporation Information

    Table 111. AstraZeneca Description and Business Overview

    Table 112. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 113. AstraZeneca Bipolar Disorder Therapeutics Drugs Product

    Table 114. AstraZeneca Recent Development

    Table 115. Allergan Corporation Information

    Table 116. Allergan Description and Business Overview

    Table 117. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 118. Allergan Bipolar Disorder Therapeutics Drugs Product

    Table 119. Allergan Recent Development

    Table 120. Bristol-Myers Squibb Corporation Information

    Table 121. Bristol-Myers Squibb Description and Business Overview

    Table 122. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 123. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product

    Table 124. Bristol-Myers Squibb Recent Development

    Table 125. GSK Corporation Information

    Table 126. GSK Description and Business Overview

    Table 127. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 128. GSK Bipolar Disorder Therapeutics Drugs Product

    Table 129. GSK Recent Development

    Table 130. Janssen Corporation Information

    Table 131. Janssen Description and Business Overview

    Table 132. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 133. Janssen Bipolar Disorder Therapeutics Drugs Product

    Table 134. Janssen Recent Development

    Table 135. AbbVie Corporation Information

    Table 136. AbbVie Description and Business Overview

    Table 137. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 138. AbbVie Bipolar Disorder Therapeutics Drugs Product

    Table 139. AbbVie Recent Development

    Table 140. Youdim Corporation Information

    Table 141. Youdim Description and Business Overview

    Table 142. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 143. Youdim Bipolar Disorder Therapeutics Drugs Product

    Table 144. Youdim Recent Development

    Table 145. Delpor Corporation Information

    Table 146. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 147. Delpor Description and Business Overview

    Table 148. Delpor Bipolar Disorder Therapeutics Drugs Product

    Table 149. Delpor Recent Development

    Table 150. Lundbeck Corporation Information

    Table 151. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 152. Lundbeck Description and Business Overview

    Table 153. Lundbeck Bipolar Disorder Therapeutics Drugs Product

    Table 154. Lundbeck Recent Development

    Table 155. Intra-Cellular Therapies Corporation Information

    Table 156. Intra-Cellular Therapies Description and Business Overview

    Table 157. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 158. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product

    Table 159. Intra-Cellular Therapies Recent Development

    Table 160. Novartis Pharmaceuticals Corporation Corporation Information

    Table 161. Novartis Pharmaceuticals Corporation Description and Business Overview

    Table 162. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 163. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product

    Table 164. Novartis Pharmaceuticals Corporation Recent Development

    Table 165. Noven Pharmaceuticals Corporation Information

    Table 166. Noven Pharmaceuticals Description and Business Overview

    Table 167. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 168. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product

    Table 169. Noven Pharmaceuticals Recent Development

    Table 170. Otsuka Corporation Information

    Table 171. Otsuka Description and Business Overview

    Table 172. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 173. Otsuka Bipolar Disorder Therapeutics Drugs Product

    Table 174. Otsuka Recent Development

    Table 175. Pfizer Corporation Information

    Table 176. Pfizer Description and Business Overview

    Table 177. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 178. Pfizer Bipolar Disorder Therapeutics Drugs Product

    Table 179. Pfizer Recent Development

    Table 180. Reviva Pharmaceuticals Corporation Information

    Table 181. Reviva Pharmaceuticals Description and Business Overview

    Table 182. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 183. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product

    Table 184. Reviva Pharmaceuticals Recent Development

    Table 185. Production Base and Market Concentration Rate of Raw Material

    Table 186. Key Suppliers of Raw Materials

    Table 187. Bipolar Disorder Therapeutics Drugs Distributors List

    Table 188. Bipolar Disorder Therapeutics Drugs Customers List

    Table 189. Bipolar Disorder Therapeutics Drugs Market Trends

    Table 190. Bipolar Disorder Therapeutics Drugs Market Drivers

    Table 191. Bipolar Disorder Therapeutics Drugs Market Challenges

    Table 192. Bipolar Disorder Therapeutics Drugs Market Restraints

    Table 193. Research Programs/Design for This Report

    Table 194. Key Data Information from Secondary Sources

    Table 195. Key Data Information from Primary Sources

List of Figures

    Figure 1. Bipolar Disorder Therapeutics Drugs Product Picture

    Figure 2. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2021 & 2027

    Figure 3. Type I Product Picture

    Figure 4. Type II Product Picture

    Figure 5. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2021 & 2027

    Figure 6. lumateperone Examples

    Figure 7. Central Nervous System (CNS) Disorders Examples

    Figure 8. Global Bipolar Disorder Therapeutics Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027

    Figure 9. Global Bipolar Disorder Therapeutics Drugs Sales Growth Rate (2016-2027) & (US$ Million)

    Figure 10. Global Bipolar Disorder Therapeutics Drugs Sales (K Units) Growth Rate (2016-2027)

    Figure 11. Global Bipolar Disorder Therapeutics Drugs Price Trends Growth Rate (2016-2027) (USD/Unit)

    Figure 12. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region: 2016 VS 2021

    Figure 13. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region: 2021 VS 2027

    Figure 14. North America Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)

    Figure 15. North America Bipolar Disorder Therapeutics Drugs Sales (K Units) Growth Rate (2016-2027)

    Figure 16. Europe Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)

    Figure 17. Europe Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)

    Figure 18. China Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)

    Figure 19. China Bipolar Disorder Therapeutics Drugs Sales (Million USD) and Growth Rate (2016-2027)

    Figure 20. Japan Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)

    Figure 21. Japan Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)

    Figure 22. Southeast Asia Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)

    Figure 23. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)

    Figure 24. India Bipolar Disorder Therapeutics Drugs Revenue (Million USD) Growth Rate (2016-2027)

    Figure 25. India Bipolar Disorder Therapeutics Drugs Sales (Million USD) Growth Rate (2016-2027)

    Figure 26. Global 5 Largest Bipolar Disorder Therapeutics Drugs Players Market Share by Revenue in Bipolar Disorder Therapeutics Drugs: 2016 & 2020

    Figure 27. Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

    Figure 28. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2016-2021)

    Figure 29. Global Bipolar Disorder Therapeutics Drugs Revenue Growth Rate by Type in 2016 & 2020

    Figure 30. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2016-2021)

    Figure 31. Global Bipolar Disorder Therapeutics Drugs Revenue Growth Rate by Application in 2016 & 2020

    Figure 32. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020

    Figure 33. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020

    Figure 34. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020

    Figure 35. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020

    Figure 36. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020

    Figure 37. China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020

    Figure 38. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020

    Figure 39. Japan Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020

    Figure 40. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020

    Figure 41. Southeast Asia Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020

    Figure 42. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020

    Figure 43. India Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020

    Figure 44. Key Raw Materials Price Trend

    Figure 45. Manufacturing Cost Structure of Bipolar Disorder Therapeutics Drugs

    Figure 46. Manufacturing Process Analysis of Bipolar Disorder Therapeutics Drugs

    Figure 47. Bipolar Disorder Therapeutics Drugs Industrial Chain Analysis

    Figure 48. Channels of Distribution

    Figure 49. Distributors Profiles

    Figure 50. Bottom-up and Top-down Approaches for This Report

    Figure 51. Data Triangulation

    Figure 52. Key Executives Interviewed